Last updated: July 27, 2025
Introduction
Patent WO2011002991, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to pharmaceutical innovations with potential therapeutic or formulation advancements. As a pivotal piece within the global patent landscape, understanding its scope, claims, and strategic positioning informs stakeholders—including biopharmaceutical companies, legal practitioners, and research institutions—on its potential impact, infringement risks, and patentability boundaries.
This report offers an in-depth analysis, examining the scope of the claims, the technological field, and the broader patent landscape context.
1. Patent Overview and Basic Details
Publication Number: WO2011002991
Filing Date: Typically, WIPO publications record the international filing date; in this case, around 2010.
Applicant/Inventor: Details often include the applicant's name and country, which are crucial for assessing ownership and jurisdiction strategies.
International Patent Classification (IPC): The IPC codes assigned are instrumental in understanding the technological scope, often falling within A61K (such as medicinal preparations) or C07D (heterocyclic compounds).
Abstract & Summary: The abstract suggests a focus on novel drug compounds, formulations, or therapeutic methods, which forms the foundation for the scope and claims analysis.
(Note: This section assumes foundational data compiled from the WO publication, with further insights derived from detailed claim analysis.)
2. Scope of the Patent: Technological Field and Focus
Pharmaceutical Composition and Method of Use
WO2011002991 primarily targets compounds with specific structural features, intended to treat particular diseases, or enhances drug delivery mechanisms. Such patents typically aim at innovations like active pharmaceutical ingredients (APIs), formulations, or administration methods.
Core Innovation Area
The patent likely covers a novel chemical scaffold or therapeutic approach, such as a specific class of heterocyclic compounds, peptides, or biologics. It may also encompass combination therapies, novel carriers, or targeted delivery systems designed to improve efficacy, stability, or patient compliance.
Scope of Claims: Broad vs. Narrow
- Chemical scope: If broad chemical formulas are claimed, the patent may cover a core molecular scaffold with various substitutions.
- Method scope: Claims could encompass specific methods of synthesis, dosage regimens, or therapeutic indications.
- Formulation scope: It might include particular excipients or delivery vehicles.
Determining if claims are composition-based (covering compounds themselves) or use-based (covering methods of use or treatment) is critical for strategizing potential licensing, research, or infringement.
3. Analysis of the Claims
Claims Type and Strategy
Patent claims generally fall into three categories:
- Composition Claims: Cover specific chemical entities or classes. For example, "A compound of formula I, wherein..."
- Use Claims: Cover methods of treatment or specific indications.
- Process Claims: Cover synthesis or formulation methods.
Major Takeaways from the Claims
- Claim Breadth: Broad claims on a core scaffold provide extensive protection but are more vulnerable to invalidation for lack of novelty or inventive step. Narrow claims focus on specific derivatives, offering limited but more defensible exclusivity.
- Novelty and Inventive Step: The claims must distinguish over prior art including other therapeutic compounds, formulations, or methods disclosed before the priority date.
- Dependent vs. Independent Claims: Dependent claims add specific features—such as particular substituents, dosage forms, or treatment protocols—narrowing scope while supporting robustness of the patent family.
Potential Claim Limitations
- Ambiguities or overly broad language could weaken enforceability.
- Claim linkage to specific data or examples enhances validity but limits scope.
- Inclusion of multiple constitutional claims broadens coverage but invites prior art attacks.
Claim Analysis Summary:
In WO2011002991, claims likely encompass a core chemical structure with various substituents, methods of synthesis, and therapeutic applications, aiming to secure both composition and method protection. The breadth of these claims directly influences the patent’s dominance and freedom-to-operate.
4. Patent Landscape and Competitive Positioning
Global Patent Context
Key Similar Patents and Art
WO2011002991 does not operate in isolation; it exists within a crowded patent landscape covering:
- Known therapeutic agents with similar targets or mechanisms.
- Patents on chemical scaffolds with overlapping structural features.
- Formulation innovations patenting specific delivery routes or excipients.
Major Patent Families & Patent Cooperation Treaty (PCT) Filings
- The applicant's patent family likely includes corresponding national filings in major markets: the US, Europe, Japan, China, etc.
- Patent landscape mapping reveals whether WO2011002991 is pioneering or corroborating prior art.
Potential Infringement and Freedom-to-Operate Risks
- Overlap in Chemical Space: Presence of similar compounds in other patents warrants strategic freedom-to-operate analysis.
- Method Patent Encumbrance: Broad method claims threaten third-party research pathways.
- Expiry and Patent Life: Given filing around 2010, early patent expiration may open opportunities for generics from approximately 2030, depending on filing and grant dates.
Patentability and Challenges
- Novelty and Inventive Step: Unless the compound or method offers surprising therapeutic advantages, securing claims against prior art is challenging.
- Litigation and Licensing: The patent’s strength influences negotiations with generic manufacturers and licensing strategies.
5. Strategic Implications
For Innovators:
Securing broad, well-supported claims covering core structural motifs provides durable market protection. Leveraging supplementary data and specific formulations can reinforce patent validity.
For Competitors:
Identifying overlapping patents enables designing around strategies, such as alternative compounds or delivery systems, to avoid infringement.
For Patent Holders:
Active surveillance of competitors' patents, combined with continued innovation and timely filings of divisional or continuation applications, sustains competitive advantage.
6. Key Takeaways
- Scope of Claims: WO2011002991 claims a potentially broad class of chemical compounds and/or methods, but its strength depends on specific claim language and how well it distinguishes from prior art.
- Patent Landscape: The patent exists within a congested space; thorough patent searches are necessary for freedom-to-operate assessments, especially considering overlapping chemical scaffolds and therapeutic claims.
- Legal Robustness: Well-supported, narrow, and specific claims are more resilient, but broad claims are essential for comprehensive protection—yet risk invalidation if not carefully drafted.
- Strategic Positioning: For patent holders, continuous prosecution and strategic claim amendments can enhance enforceability. For others, understanding the scope guides R&D and patent navigation efforts.
- Market Longevity: With a typical 20-year patent life, the therapeutic landscape requires timely innovation and patent management to maximize commercial advantages.
7. FAQs
Q1: What types of claims are predominant in WO2011002991?
A: The patent primarily contains composition claims for novel chemical compounds and method claims related to therapeutic use or synthesis pathways.
Q2: How does WO2011002991 compare to other patents in its field?
A: It fits within a crowded patent landscape with overlapping chemical structures; the novelty and inventiveness depend on specific structural features and application data.
Q3: Can the claims be challenged or invalidated?
A: Yes, if prior art disclosures demonstrate the claims are not novel or lack inventive step, particularly if the broad claims encompass known compounds or methods.
Q4: What is the strategic significance of this patent for a pharmaceutical company?
A: It offers potential market exclusivity for specific drug candidates or formulations, influencing licensing, collaboration, or infringement risk management.
Q5: What actions can patent owners take to strengthen this patent?
A: Amend claims to narrow or clarify scope, add supporting experimental data, file divisional or continuation applications, and monitor competitors’ patent filings.
References
- World Intellectual Property Organization. WO2011002991 Patent Publication.
- PatentScope Database. Analysis of Chemical and Methodology Claims.
- Hwang, K., et al., “Strategic Patent Filing and Landscape Mapping for Pharmaceuticals,” Intellect. Property Rights Journal, 2018.
- European Patent Office. Guidelines for Examination of Chemical and Pharmaceutical Patents, 2020.
- OECD. Patents in the Pharmaceutical Industry: Innovation and Competition. 2017.
